$Oncternal Therapeutics, Inc.(ONCT)$Confirms Lentigen technology to manufacture lentiviralvectors for its ROR1-targeting CAR-T cell therapy program
$Oncternal Therapeutics, Inc.(ONCT)$Confirms Lentigen technology to manufacture lentiviralvectors for its ROR1-targeting CAR-T cell therapy program
精彩评论